Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle H Nelson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Science Immunology|August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axisSaleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
Science Advances|June 12, 2020
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunityEphraim A Ansa-Addo, Huai-Cheng Huang, Brian Riesenberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2023
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cellsMegan M Wyatt, Logan W Huff, Michelle H Nelson, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Science Immunology|August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axisSaleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
Science Advances|June 12, 2020
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunityEphraim A Ansa-Addo, Huai-Cheng Huang, Brian Riesenberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2023
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cellsMegan M Wyatt, Logan W Huff, Michelle H Nelson, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 3